Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
FSD Pharma (DE:0K9A)
FRANKFURT:0K9A
FSD Pharma (0K9A) Stock Price & Analysis
0 Followers
0K9A Stock Chart & Stats
Day’s Range€1.04 - €1.04
52-Week Range― - ―
Previous Close€1.15
Volume0.00
Average Volume (3M)N/A
Market Cap
$44.09M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next Earnings
Mar 29, 2024EPS Estimate
-€0.13Last Dividend Ex-Date
Nov 27, 2023Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
FSD Pharma News
0K9A FAQ
What was FSD Pharma’s price range in the past 12 months?
Currently, no data Available
What is FSD Pharma’s market cap?
Currently, no data Available
When is FSD Pharma’s upcoming earnings report date?
FSD Pharma’s upcoming earnings report date is Mar 29, 2024 which is 34 days ago.
How were FSD Pharma’s earnings last quarter?
FSD Pharma released its earnings results on Nov 14, 2023. The company reported -€0.027 earnings per share for the quarter, beating the consensus estimate of -€0.127 by €0.1.
Is FSD Pharma overvalued?
According to Wall Street analysts FSD Pharma’s price is currently Overvalued.
Does FSD Pharma pay dividends?
FSD Pharma pays a Notavailable dividend of <€0.01 which represents an annual dividend yield of N/A. See more information on FSD Pharma dividends here
What is FSD Pharma’s EPS estimate?
FSD Pharma’s EPS estimate is -€0.13.
How many shares outstanding does FSD Pharma have?
Currently, no data Available
What happened to FSD Pharma’s price movement after its last earnings report?
FSD Pharma reported an EPS of -€0.027 in its last earnings report, beating expectations of -€0.127. Following the earnings report the stock price went up 3.351%.
Which hedge fund is a major shareholder of FSD Pharma?
Currently, no hedge funds are holding shares in DE:0K9A
---
FSD Pharma Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
18.91%
12-Months-Change
Fundamentals
Return on Equity
-89.16%
Trailing 12-Months
Asset Growth
-56.54%
Trailing 12-Months
Company Description
FSD Pharma
FSD Pharma, Inc. is a specialty biotech pharmaceutical research and development company. It focuses on developing over time a robust pipeline of FDA-approved synthetic compounds targeting the endocannabinoid system of the human body to treat certain diseases of the central nervous system and autoimmune disorders of the skin, GI tract, and the musculoskeletal system. The company was founded by Thomas Fairfull, Zeeshan Saeed and Anthony J. Durkacz in 1994 and is headquartered in Cobourg, Canada.
---
Technical Analysis
---